Rivernorth Capital Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Rivernorth Capital Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-172,050	Closed	-$1.76M	–	704
2023 Q1	$1.76M	Hold	172,050	–	–	0.09%	206
2022 Q4	$1.73M	Hold	172,050	–	–	0.08%	244
2022 Q3	$1.7M	Hold	172,050	–	–	0.08%	279
2022 Q2	$1.68M	Hold	172,050	–	–	0.07%	271
2022 Q1	$1.68M	Sell	172,050 -2,935	-2%	-$28.5K	0.06%	274
2021 Q4	$1.71M	Hold	174,985	–	–	0.07%	239
2021 Q3	$1.71M	Buy	+174,985	New	+$1.71M	0.09%	185

Rivernorth Capital Management's ORIA Position: Q2 2023 in Review

Rivernorth Capital Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 172,050 shares — an estimated $1.76M sold.

Rivernorth Capital Management first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $1.76M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Rivernorth Capital Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Rivernorth Capital Management sold 172,050 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.76M.
Rivernorth Capital Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
Rivernorth Capital Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $1.76M in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Rivernorth Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.